Literature DB >> 12400940

Mechanistic and genetic studies of radiation tumorigenesis in the mouse--implications for low dose risk estimation.

Simon Bouffler1, Andrew Silver, Roger Cox.   

Abstract

Radiation cancer risk estimates remain firmly based upon epidemiological data. Experimental validation of the fundamental aspects of these risk estimates relies on animal studies. In particular, animal model systems for radiation carcinogenesis can provide data for mechanistic modelling approaches to risk estimation. The accuracy and validity of risk estimation models developed will depend upon the extent of our understanding of the process of radiation carcinogenesis. The study of 'spontaneous' tumours in humans continues to provide a sound context in which to consider the mechanisms of radiation carcinogenesis. Several mouse radiation carcinogenesis systems are considered here with particular reference to the nature of the initiating event and the influence of genetic susceptibility on radiation-induced cancer.

Entities:  

Mesh:

Year:  2002        PMID: 12400940     DOI: 10.1088/0952-4746/22/3a/302

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  3 in total

1.  Liver transplant-related anastomotic biliary strictures: a novel, rapid, safe, radiation-sparing, and cost-effective management approach.

Authors:  Monique T Barakat; Robert J Huang; Nirav C Thosani; Abhishek Choudhary; Mohit Girotra; Subhas Banerjee
Journal:  Gastrointest Endosc       Date:  2017-07-27       Impact factor: 9.427

2.  Radiation Training, Radiation Protection, and Fluoroscopy Utilization Practices Among US Therapeutic Endoscopists.

Authors:  Saurabh Sethi; Monique T Barakat; Shai Friedland; Subhas Banerjee
Journal:  Dig Dis Sci       Date:  2019-03-25       Impact factor: 3.199

Review 3.  Cell cycle regulators guide mitochondrial activity in radiation-induced adaptive response.

Authors:  Aris T Alexandrou; Jian Jian Li
Journal:  Antioxid Redox Signal       Date:  2014-02-14       Impact factor: 8.401

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.